Authors: Altarescu, G Hill, S Wiggs, E Jeffries, N Kreps, C Parker , CC Brady, RO Barton, NW Schiffmann, R Bannarjee, TK Crutchfield, K Frei, K McKee, MA Moore, DF Tournay, A

Citation: G. Altarescu et al., The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease, J PEDIAT, 138(4), 2001, pp. 539-547

Authors: Altarescu, G Schiffmann, R Parker, CC Moore, DF Kreps, C Brady, RO Barton, NW

Citation: G. Altarescu et al., Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease, BL CELL M D, 26(4), 2000, pp. 285-290

Authors: Scott, LJC Griffin, JW Luciano, C Barton, NW Banerjee, T Crawford, T McArthur, JC Tournay, A Schiffmann, R

Citation: Ljc. Scott et al., Quantitative analysis of epidermal innervation in Fabry disease, NEUROLOGY, 52(6), 1999, pp. 1249-1254

Authors: Rodrigue, SW Rosenthal, DI Barton, NW Zurakowski, D Mankin, HJ

Citation: Sw. Rodrigue et al., Risk factors for osteonecrosis in patients with type 1 Gaucher's disease, CLIN ORTHOP, (362), 1999, pp. 201-207